Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GSTS Pathology Innovation Academy Demonstrates the Impact of Personalized Medicine

Published: Wednesday, December 18, 2013
Last Updated: Wednesday, December 18, 2013
Bookmark and Share
Second Innovation Academy attracts more than 100 delegates to the Royal Institution of Great Britain.

The second Innovation Academy hosted by GSTS Pathology, attracted more than 100 delegates to the Royal Institution of Great Britain on Friday 6th December 2013.

The theme of the symposium - ‘Personalized medicine: today’s reality, not just a promise for tomorrow’, examined advances in three areas - therapeutic drug monitoring, infectious diseases and transplantation, and oncology - with particular recognition of the impact personalized medicine is making in healthcare.

For more than 200 years the Royal Institution of GB has been home to eminent scientists whose discoveries have helped to shape the modern world, making it a particularly inspiring venue for this Innovation Academy event. Speakers included respected scientists and clinicians from across healthcare, industry and GSTS Pathology.

The Innovation Academy aims to support and showcase scientific innovations developed at GSTS and how they can improve patient care now and in the future.

Fiona Carragher, Deputy Chief Scientific Officer for England, opened the meeting by discussing the many challenges facing today’s heath service and how they can be addressed. “Science will be crucial in this, with research constantly informing new ways of working. While personalized medicine has been in use for a long time - for example INR measurement in anticoagulation therapy - it is clear that genomics and personalized medicine continue to be at the forefront of many new techniques.”

Dr Dominic Harrington, Scientific Director, GSTS Pathology, co-organized the symposium. “Personalized medicine isn’t just a theoretical research idea, but offers practical solutions for tailoring and monitoring therapies in a wide variety of clinical conditions, delivering improvements in patient care today. The Innovation Academy aims to create an environment supportive of innovation, quality and the development of our future scientific leaders. We know that good science equals good medicine.”

As the UK’s leading independent provider of pathology services, GSTS Pathology LLP provides a full suite of clinically led pathology services that make a real difference to patient care.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!